Upstream Bio, Inc.(UPB)
$2.78-0.08 (-2.80%)
UPB
Upstream Bio, Inc. financials statements
$2.78
At close:-0.08 (-2.80%)
Want to see UPB full AI Analyst Report?
Upstream Bio, Inc. (UPB) Ratios
266 Followers
Upstream Bio, Inc. Ratios
UPB's free cash flow for Q3 2026 was $-54.23M. For the 2026 fiscal year, UPB's free cash flow was increased by $0.00 and operating cash flow was $-54.23M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 26.15 | 44.63 | 17.96 | 3.77 |
| Quick Ratio | 26.15 | 44.63 | 17.96 | 3.77 |
| Cash Ratio | 7.55 | 30.35 | 3.97 | 3.51 |
| Solvency Ratio | -10.23 | -5.28 | -0.09 | -0.19 |
| Operating Cash Flow Ratio | -9.91 | -5.51 | -5.82 | -3.92 |
| Short-Term Operating Cash Flow Coverage | -185.10 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 337.80M | $ 467.29M | $ -123.33M | $ -106.33M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | -0.00 | -0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | -0.00 | -0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.03 | -0.95 | -0.17 |
| Debt Service Coverage Ratio | -198.97 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.04 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.70 | 5.17 | 0.64 | 0.71 |
| Profitability Margins | ||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -5026.03% | -2650.04% | -1685.46% | -1972.69% |
| EBITDA Margin | -5019.45% | -2646.29% | -1682.94% | -1972.11% |
| Operating Profit Margin | -5618.82% | -3281.18% | -1685.46% | -1972.69% |
| Pretax Profit Margin | -5026.03% | -2650.04% | -862.90% | -1969.31% |
| Net Profit Margin | -5026.03% | -2650.04% | -862.90% | -1969.31% |
| Continuous Operations Profit Margin | -5026.03% | -2650.04% | -862.90% | -1969.31% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 89.45% | 80.76% | 51.20% | 99.83% |
| Return on Assets (ROA) | -40.55% | -13.04% | -17.52% | -129.17% |
| Return on Equity (ROE) | -42.22% | -13.37% | 16.68% | 22.48% |
| Return on Capital Employed (ROCE) | -47.12% | -16.51% | -36.24% | -175.52% |
| Return on Invested Capital (ROIC) | -47.02% | -16.49% | -36.23% | -174.40% |
| Return on Tangible Assets | -40.55% | -13.04% | -17.52% | -129.17% |
| Earnings Yield | -9.81% | -7.44% | -2.57% | -2.99% |
| Efficiency Ratios | ||||
| Receivables Turnover | 4.27 | 2.01 | 10.08 | 2.94 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.60 | 1.00 | 11.78 | 7.39 |
| Asset Turnover | 0.01 | 0.00 | 0.02 | 0.07 |
| Working Capital Turnover Ratio | 0.01 | 0.01 | 0.04 | 0.00 |
| Cash Conversion Cycle | 85.43 | 181.73 | 36.19 | 124.08 |
| Days of Sales Outstanding | 85.43 | 181.73 | 36.19 | 124.08 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 85.43 | 181.73 | 36.19 | 124.08 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -2.47 | -1.15 | -1.04 | -0.52 |
| Free Cash Flow Per Share | -2.48 | -1.16 | -1.05 | -0.53 |
| Dividend Paid and CapEx Coverage Ratio | -807.73 | -115.80 | -263.38 | -231.96 |
| Capital Expenditure Coverage Ratio | -807.73 | -115.80 | -263.38 | -231.96 |
| Operating Cash Flow Coverage Ratio | -105.02 | -32.26 | -842.80 | -202.35 |
| Operating Cash Flow to Sales Ratio | -46.70 | -24.97 | -15.94 | -15.69 |
| Free Cash Flow Yield | -9.13% | -7.07% | -4.76% | -2.39% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -10.21 | -11.03 | -38.91 | -33.48 |
| Price-to-Sales (P/S) Ratio | 512.30 | 356.14 | 335.76 | 659.33 |
| Price-to-Book (P/B) Ratio | 4.30 | 1.80 | -6.49 | -7.53 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.96 | -14.14 | -20.99 | -41.83 |
| Price-to-Operating Cash Flow Ratio | -10.97 | -14.26 | -21.07 | -42.01 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | -0.26 | -0.66 | 0.00 |
| Enterprise Value Multiple | -9.51 | -8.29 | -19.31 | -32.72 |
| Enterprise Value | 1.36B | 520.00M | 773.33M | 782.16M |
| EV to EBITDA | -9.51 | -8.29 | -19.31 | -32.72 |
| EV to Sales | 477.15 | 219.41 | 324.93 | 645.34 |
| EV to Free Cash Flow | -10.21 | -8.71 | -20.31 | -40.94 |
| EV to Operating Cash Flow | -10.22 | -8.79 | -20.39 | -41.12 |
| Tangible Book Value Per Share | 6.31 | 9.15 | -3.39 | -2.92 |
| Shareholders’ Equity Per Share | 6.31 | 9.15 | -3.39 | -2.92 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.05 | 0.05 | 0.07 | 0.03 |
| Net Income Per Share | -2.66 | -1.22 | -0.57 | -0.66 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.51 | 1.00 |
| Research & Development to Revenue | 47.93 | 26.57 | 13.36 | 15.39 |
| SG&A to Revenue | 9.25 | 7.24 | 4.49 | 5.33 |
| Stock-Based Compensation to Revenue | 3.62 | 2.53 | 1.44 | 1.06 |
| Income Quality | 0.93 | 0.94 | 1.85 | 0.80 |
Currency in USD
